MICC Injection (Olympia) – Sterility Concerns (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounded by Olympia Pharmacy, Orlando, FL
Brand
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Lot Codes / Batch Numbers
Lots: L5306 Exp 11/30/13 and C5414 Exp 9/21/13 25/50/330 Lot L5118 Exp 12/31/13
Products Sold
Lots: L5306 Exp 11/30/13 and C5414 Exp 9/21/13 25/50/330 Lot L5118 Exp 12/31/13
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounde due to Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026